Q3 Earnings Forecast for CVE:HIV Issued By Northland Capmk

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Equities research analysts at Northland Capmk lifted their Q3 2026 earnings per share estimates for shares of HIVE Blockchain Technologies in a report released on Wednesday, January 29th. Northland Capmk analyst M. Grondahl now anticipates that the company will earn $0.11 per share for the quarter, up from their prior forecast of $0.07.

A number of other equities research analysts have also recently weighed in on the company. Keefe, Bruyette & Woods raised HIVE Blockchain Technologies to a “moderate buy” rating in a report on Wednesday, January 8th. Roth Capital raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Wednesday, December 18th. Finally, Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th. Four analysts have rated the stock with a strong buy rating, According to data from MarketBeat.com, the stock presently has an average rating of “Strong Buy”.

HIVE Blockchain Technologies Price Performance

HIVE Blockchain Technologies (CVE:HIV) last announced its quarterly earnings results on Tuesday, November 12th. The company reported C($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of C($0.12) by C$0.04. During the same quarter last year, the company posted ($0.39) EPS.

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.